Crizotinib
Dec. 26, 2024
Crizotinib - Wikipedia FDA approves crizotinib for ALK-positive inflammatory myofibroblastic tumor — ALK POSITIVE Xalkori (crizotinib) Cancer Medication - Cancer Health Crizotinib (PF-02341066) | ALK/c-Met/ROS1 Inhibitor | MedChemExpress | Crizotinib